NEW ORLEANS, Dec. 1, 2017 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 2, 2018 to file lead plaintiff applications in a securities class action lawsuit against Novan, Inc. (NasdaqGM: NOVN), if they purchased the Company's shares between the expanded period of September 26, 2016 and August 1, 2017 (the "Class Period") and/or pursuant to its September 26, 2016 initial public offering ("IPO"). This action is pending in the United States District Court for the Middle District of North Carolina.
Novan investors should visit us at https://www.claimsfiler.com/cases/view-novan-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Novan and certain of its executives are charged with failing to disclose material information during the class period, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company had initiated and conducted two identical Phase 3 clinical trials for its lead product candidate, SB204; (ii) in fact, the two SB204 Phase 3 clinical trials were not identical; and (iii) as a result of the foregoing, Novan's financial statements were materially false and misleading at all relevant times.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.